Targeted Protein Degradation (TPD) is a hot topic in drug discovery today. PROteolysis Targeting Chimeras (PROTACs) and molecular glues provide an approach for the targeted degradation of a protein of interest (POI) with a small molecule.

SpiroChem discovery team has identified leads across several projects.

On PROTACs and molecular glues projects, SpiroChem chemists bring support for:

  • Developing efficient synthesis of E3 ligase recruiters such as Thalidomide, Lenalidomide, VHL, ….
  • Introducing diversified handles on E3 ligase recruiters
  • Connecting various warheads

For PROTACs projects, SpiroChem chemists use their expertise for escaping from usual PEG linkers.

Linker
PEG Linker
  • High risk of hydrophobic collapse
  • Low solubility
  • Limited IP space
SpiroChem linkers
SpiroChem designs novel linkers containing 3D constrained modules to:
  • Minimize hydrophobic collapse and reduce the risk of aggregation of the complex
  • Improve PhysChem properties of the complex
  • Generate novel IP space

We will be happy to support your projects.

For more information, please contact Laurence Jung at laurence.jung@spirochem.com.